Cancer/testis antigens: Structural and immunobiological properties

Cancer Investigation

Volumn 20, Issue 2, 2002, Pages 222-236

  Kirkin, Alexei F ^a   Dzhandzhugazyan, Karine N ^a   Zeuthen, Jesper ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CELL ADHESION MOLECULE; EPITOPE; PROTEIN MAGE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIGEN STRUCTURE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOGENICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; REVIEW;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; EPITOPES; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NEOPLASMS; PROTEIN STRUCTURE, SECONDARY; TESTIS;

EID: 0036199654     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120001150     Document Type: Review

References (106)

1. Human tumor antigens recognized by T lymphocytes
2. Melanoma-associated antigens recognized by cytotoxic T lymphocytes
3. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
4. SSX: A multigene family with several members transcribed in normal testis and human cancer
5. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes
6. Structure, chromosomal localization, and expression of 12 genes of the MAGE family
7. MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus
8. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma
9. Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries
10. Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product
11. Human Gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
12. A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes
13. Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family
14. A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12
15. + cytotoxic T cells in association with histocompatibility leukocyte antigen DR11
16. + T lymphocytes
17. Infrequent expression of the MAGE gene family in uveal melanomas
18. Genes coding for tumor antigens recognized by cytolytic T lymphocytes
19. High frequency of the MAGE-1 gene expression in hepatocellular carcinoma
20. A tumour-associated antigen expression in human haematological malignancies
21. Expression of the MAGE gene family in human lymphocytic leukemia
22. Expression of gene MAGE-A4 in Reed-Sternberg cells
23. Alternative promoters of gene MAGE4a
24. Immunobiology of pregnancy
25. Expression of MAGE genes in primary and metastatic cutaneous melanoma
26. Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas
27. Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: Correlation with stage of disease
28. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder
29. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
30. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
31. Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins
32. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
33. Isolation and characterization of a MAGE gene family in the Xp21.3 region
34. A family of rapidly evolving genes from the sex reversal critical region in Xp21
35. The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes
36. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
37. Identification of multiple cancer/testis antigens by allogeneic anti-body screening of a melanoma cell line library
38. CT10: A new Cancer-Testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis
39. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region
40. The human chromosomal gene for necdin, a neuronal growth suppressor, in the Prader-Willi syndrome deletion region
41. Identification of a new, unorthodox member of the MAGE gene family
42. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells
43. Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation
44. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
45. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
46. Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens
47. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
48. PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus
49. Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database
50. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
51. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells
52. Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene
53. The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells
54. Human neoplasms elicit multiple specific immune responses in the autologous host
55. Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28
56. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
57. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames
58. + T lymphocytes of patients with NY-ESO-1-expressing melanoma
59. LAGE-1, a new gene with tumor specificity
60. The SSX-2 gene, which is involved in the t(X,18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40
61. Krüppel-associated boxes are potent transcriptional repression domains
62. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens
63. Human synaptonemal complex protein 1 (SCP1): Isolation and characterization of the cDNA and chromosomal localization of the gene
64. Expression of testicular genes in haematological malignancies
65. CTp11, a novel member of the family of human cancer/testis antigens
66. Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer
67. Expression of cancer-testis antigens in lung cancer: Definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9
68. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes
69. Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
70. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients
71. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine
72. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
73. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma
74. Identification of human testis-specific transcripts and analysis of their expression in tumor cells
75. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter
76. Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
77. A phase II study of 5-aza-2′-deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer
78. Immunologically privileged sites
79. Immunohistochemical detection of intercellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex class I antigens in seminoma
80. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis
81. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides
82. Proteolysis, proteasomes and antigen presentation
83. Conformational constraints in protein degradation by the 20S proteasome
84. GOR method for predicting protein secondary structure from amino acid sequence
85. Non-globular domains in protein sequences: Automated segmentation using complexity measures
86. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
87. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
88. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes
89. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules
90. Dendritic cells
91. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis
92. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
93. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
94. A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes
95. A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes
96. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLACw*1601
97. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes
98. + T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients
99. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3
100. Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24
101. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted Cytotoxic T lymphocytes
102. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response
103. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3
104. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human Histocompatibility Leukocyte Antigen (HLA)-A2-binding peptide epitopes
105. + T cell epitopes from NY-ESO-1 presented by HLA-DR molecules
106. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1